PARIS: US health authorities have suspended the licence for the Ixchiq vaccine against the chikungunya virus following reports of “serious adverse events”, the drug’s French maker said today. Ixchiq ...
Healthcare providers should pause in their use of the chikungunya live vaccine (Ixchiq) while investigation of serious neurologic, cardiac, and other adverse events in vaccine recipients is ongoing, ...
Newswise — A new study published in PNAS suggests that rare cases of brain inflammation linked to live-attenuated yellow fever and Chikungunya vaccines were due to autoantibodies carried in a small ...
The symptoms come on quickly — acute fever, followed by debilitating joint pain that can last for months. Though rarely fatal, the chikungunya virus, a mosquito-borne illness, can be particularly ...
COPENHAGEN, Denmark, June 29, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Health Canada has approved VIMKUNYA® (recombinant, adsorbed) for immunization to prevent disease caused by ...
A new analysis shows that targeting high-risk regions with the IXCHIQ vaccine could dramatically curb the global impact of chikungunya, offering hope against this rapidly spreading mosquito-borne ...
The Centers for Disease Control and Prevention has accepted an advisory panel’s recommendations on vaccines for chikungunya disease, which is transmitted to humans by mosquitoes. The recommendations ...
Add Yahoo as a preferred source to see more of our stories on Google. https://www.tipranks.com/news/the-fly/trump-trade-president-to-sign-order-on-psychedelic-used ...
NEW YORK — The U.S. government advised American travelers age 60 and older not get a chikungunya vaccine as it investigates possible side effects. The Centers for Disease Control and Prevention and ...
Chikungunya vaccine update: Experimental adjuvant-free particles aim to prevent months of joint pain
Griffith University researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue. Professor Bernd Rehm, from Griffith's Institute for ...
The US government advised American travelers age 60 and older not get a chikungunya vaccine as it investigates possible side effects, the AP reports. The Centers for Disease Control and Prevention and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results